Study Finds Ginkgo Biloba Doesn’t Prevent Dementia
New research challenges the common claim that Ginkgo biloba can keep dementia at bay, suggesting the herb may be more useful after cognitive decline has begun rather than as a preventive measure.
Systematic review finds limited preventive effect
Scientists at the University of Granada examined three decades of studies on herbal compounds for Alzheimer’s disease and mild cognitive impairment. Their systematic review, published in the International Journal of Molecular Sciences in October 2025, screened more than 500 articles and clinical trial registrations, ultimately focusing on 31 rigorously designed human trials.
Among the trials, one large prevention study followed 2,854 older adults with memory complaints for five years. The study found no statistically significant difference in Alzheimer’s diagnoses between the ginkgo group and the placebo group.
These results stand in contrast to earlier expectations that the herb could delay the onset of dementia. The researchers noted that the brain’s healthy baseline may leave little room for measurable improvement when a preventive supplement is introduced.
Ginkgo is not a cure.
Related: Clinical research validates overlooked tooth pain remedy
Evidence supports use in existing dementia
Two separate trials, each enrolling more than 400 patients already diagnosed with dementia, reported modest but consistent gains in cognitive function and daily living abilities for participants taking the same EGb 761 dosage. Both studies measured outcomes against placebo and found that the ginkgo group performed better on standard cognitive tests.
The authors attribute the divergent findings to timing. Ginkgo’s flavonoids and terpenoids appear to boost cerebral blood flow and reduce oxidative stress, effects that become noticeable when brain tissue is already under strain. In a healthy brain, the same mechanisms may not produce a detectable benefit.
Similar patterns emerged for other herbal extracts examined in the review. Compounds that showed promise for treating established cognitive decline often failed to demonstrate preventive value, a nuance rarely highlighted in product marketing.
For people already managing a dementia diagnosis, or caring for someone who is, the data provide a measured reason for optimism. However, the benefit appears linked to the specific, standardized extract EGb 761, which may differ from many over‑the‑counter supplements that lack consistent quality control.
Standardization matters because the concentration of active compounds can vary widely between manufacturers. Consumers looking for the formulation tested in clinical trials should check supplement labels for the EGb 761 designation.
Related: Hidden Bitter Seeds May Drive Metabolic Benefits
One awkward phrase in the report said “the brain’s healthy baseline may simply have less room to show improvement,” highlighting how subtle wording can affect interpretation.
From a practical standpoint, the findings suggest that early detection of cognitive changes, rather than long‑term preventive supplementation, should be the focus for those still cognitively intact. Lifestyle factors such as regular physical activity, adequate sleep, and social engagement have stronger evidence for reducing dementia risk than any single herbal supplement reviewed.
In the middle of the discussion, it becomes clear that the real value of ginkgo lies in its role as a supportive adjunct for people already experiencing memory loss. For families dealing with the challenges of dementia, a supplement that modestly improves daily function could translate into better quality of life, provided it is sourced from a reputable manufacturer.
While ginkgo may not halt the development of Alzheimer’s, its inclusion in a broader care plan—alongside evidence‑based lifestyle measures—could offer incremental benefits for symptom management. Health professionals should therefore advise patients to view the herb as part of an overall plan rather than a standalone solution.
For readers seeking more detailed guidance, reputable educational resources such as the Alzheimer’s disease overview on Wikipedia provide additional context on disease progression and recommended interventions.
